Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Caissa Capital Management ltd.. Director active across 1 company, notably Avalo Therapeutics, Inc.. Cumulatively, 18 reports have been published. Split: 18 buys · 0 sell. Total volume traded: €1.3m. History available since 10 April 2023. The latest transaction was filed on 26 June 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Caissa Capital Management ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25,000 shares@ US$2.84325.0% of flowCommon StockSEC:0001929354-23-000002:1
Canonical exit: 10 Jul 2023 (T+90)
18 of 18 declarations
About Caissa Capital Management ltd.
Caissa Capital Management ltd. is a declarant linked to Avalo Therapeutics, Inc., where it is identified as a 10% Owner. The declarant has 18 filings in total, and in the sampled recent filings all transactions are acquisitions, with buy volume of EUR 1302940 between 2023-04-11 and 2023-06-27.